$ Value
$312K
Shares
5,607
Price
$56
Filed
Nov 7
Insider
Name
Dambkowski Carl
Title
Chief Medical Officer
CIK
0001983476
Roles
Transaction Details
Transaction Date
2025-11-05
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
282,686
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.16 to $53.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.24 to $55.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.25 to $56.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.31 to $56.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | This option represents the right to purchase 175,345 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments through December 18, 2027, subject to the Reporting Person's continued service to the Issuer.
Filing Info
Dambkowski Carl's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | APGE | M | $94K |
| 2026-04-01 | APGE | ▼ | $227K |
| 2026-04-01 | APGE | ▼ | $231K |
| 2026-04-01 | APGE | ▼ | $9K |
| 2026-04-01 | APGE | M | $0 |
| 2026-02-04 | APGE | M | $94K |
| 2026-02-04 | APGE | ▼ | $161K |
| 2026-02-04 | APGE | ▼ | $93K |
| 2026-02-04 | APGE | ▼ | $87K |
| 2026-02-04 | APGE | ▼ | $7K |
Other Insiders at APGE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Henderson Jane
Chief Financial Officer
|
— | $652K | 2026-04-16 |
|
HENDERSON MICHAEL THOMAS
Chief Executive Officer
|
— | $2.9M | 2026-04-16 |
|
Dambkowski Carl
Chief Medical Officer
|
— | $828K | 2026-04-01 |